Viavi Solutions Inc. logo

Viavi Solutions Inc.

VIAV | NASDAQ
Chart Builder DCF Calculator
$29.92
-$3.40 (-10.20%)
At close: Oct 30, 2026, 4:00 PM ET
$31.78
+$1.86 (+6.21%)
Pre-market: Nov 2, 2026, 7:59 AM ET
-10.20%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026
51.8
+13.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #364/819 (Top 44%)

Key Statistics

Market Data

Market Cap $7.36B
1D Range
28.73 31.61
52W Range
15.92 55.33

Valuation (TTM)

PE -230.15
PB 5.08
EV/EBITDA 52.38

Valuation (NTM)

Forward PE 20.00
Forward PEG -3.09
Price Target $63.67
Loading financial charts...

Profile

Viavi Solutions Inc. offers a comprehensive suite of solutions for network testing, monitoring, and assurance to a global customer base. These clients include telecommunication service providers, busi...

Sector Technology
Employees 4,100
IPO Date Nov 17, 1993
Fiscal Year August - July

Latest News

VIAVI Expands AI-Native Testing with MCP Server Framework for Network and Security Testing

4 days ago · prnewswire.com

VIAVI Expands AI-Native Testing with MCP Server Framework for Network and Security Testing
VIAVI State of the Network Study: NetSecOps Deployments Increase 37% YoY, but One in Five Enterprises Still Lack a Transition Plan

12 days ago · prnewswire.com

VIAVI State of the Network Study: NetSecOps Deployments Increase 37% YoY, but One in Five Enterprises Still Lack a Transition Plan
Viavi Solutions Q1 Preview: A Lot More Attractive After The Price Reset (Rating Upgrade)

16 days ago · seekingalpha.com

Viavi Solutions Q1 Preview: A Lot More Attractive After The Price Reset (Rating Upgrade)
Viavi Solutions Inc (VIAV) Stock Down 9.3% but Still Overvalued -- GF Score: 66/100

17 days ago · gurufocus.com

Viavi Solutions Inc (VIAV) Stock Down 9.3% but Still Overvalued -- GF Score: 66/100
VIAVI Announces Date for Fiscal First Quarter 2027 Financial Results

19 days ago · prnewswire.com

VIAVI Announces Date for Fiscal First Quarter 2027 Financial Results
VIAVI T/Rx Selected by U.S. Army Threat Systems Management Office for Critical Range Modernization Initiative

20 days ago · prnewswire.com

VIAVI T/Rx Selected by U.S. Army Threat Systems Management Office for Critical Range Modernization Initiative
Viavi Exhibits More Than Threefold Growth in a Year: Should You Buy?

28 days ago · zacks.com

Viavi Exhibits More Than Threefold Growth in a Year: Should You Buy?
Can VIAV's New CF50 Strengthen Its Enterprise-Scale Testing Portfolio?

1 month ago · zacks.com

Can VIAV's New CF50 Strengthen Its Enterprise-Scale Testing Portfolio?

1 month ago · zacks.com

Should VIAV Be in Your Portfolio After a 196.4% Gain in a Year?

1 month ago · zacks.com

VIAV's NSE Segment Shows Strength: Is the Growth Story Intact?

Earnings

Next Earnings
Nov 4, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$65.00
Upside
+117.25%
Buy (6)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.